Skip to content

Zymeworks ZYME Additions for tax positions of prior years

Additions for tax positions of prior years at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
$971.75K+356%

Other financials

Income statement

See full
Revenue$2.4M-91.1%
Operating income-$47.1M-84.0%
Net income-$44.2M-95.1%
EPS (diluted)-$0.59-96.7%

Balance sheet

See full
Cash & equivalents$244.3M+221%
Total debt$17.0M-7.7%
Total equity$163.6M-49.7%
Total assets$478.2M+12.4%

Cash flow

See full
Operating cash flow-$45.7M-1,242%
CapEx$216.0K+1,250%
Free cash flow-$45.9M-1,242%

Valuation

See full
Market cap$1.79B+125%

Profitability

See full
Operating margin-140.4%+7.3pp
Net margin-126.3%+5.0pp
FCF margin-94.8%+15.5pp

Returns & leverage

See full
Return on equity-42%+29.2pp
Debt / equity0.1×0.0×
Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions.

The official record: Zymeworks’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's additions for tax positions of prior years.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zymeworks's additions for tax positions of prior years?
Zymeworks (ZYME) reported additions for tax positions of prior years of $591K in Q4 2025.
What does additions for tax positions of prior years mean?
This metric measures the increase in unrecognized tax benefits related to tax positions taken in prior reporting periods. It captures adjustments made as the company re-evaluates the sustainability of its historical tax filings. This is a key indicator of potential tax audit risk or evolving tax interpretations.